• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by UnitedHealth Group Incorporated

    7/23/24 8:33:25 PM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    FWP 1 d809300dfwp.htm FWP FWP

    Issuer Free Writing Prospectus

    Filed Pursuant to Rule 433

    Registration Statement No. 333-270279

    July 23, 2024

    UNITEDHEALTH GROUP INCORPORATED

    FINAL TERM SHEET

    Dated July 23, 2024

    $500,000,000 FLOATING RATE NOTES DUE JULY 15, 2026

    $650,000,000 4.750% NOTES DUE JULY 15, 2026

    $1,250,000,000 4.800% NOTES DUE JANUARY 15, 2030

    $1,500,000,000 4.950% NOTES DUE JANUARY 15, 2032

    $2,000,000,000 5.150% NOTES DUE JULY 15, 2034

    $1,500,000,000 5.500% NOTES DUE JULY 15, 2044

    $2,750,000,000 5.625% NOTES DUE JULY 15, 2054

    $1,850,000,000 5.750% NOTES DUE JULY 15, 2064

     

    Issuer:    UnitedHealth Group Incorporated
    Ratings (Moody’s / S&P / Fitch)*:    A2 / A+ / A
    Note Type:    SEC Registered (No. 333-270279)
    Trade Date:    July 23, 2024
    Settlement Date (T+2)**:    July 25, 2024
    Maturity Date:   

    July 15, 2026 (the “Floating Rate 2026 Notes”)

    July 15, 2026 (the “2026 Notes”)

    January 15, 2030 (the “2030 Notes”)

    January 15, 2032 (the “2032 Notes”)

    July 15, 2034 (the “2034 Notes”)

    July 15, 2044 (the “2044 Notes”)

    July 15, 2054 (the “2054 Notes”)

    July 15, 2064 (the “2064 Notes”)

    Principal Amount Offered:   

    $500,000,000 (Floating Rate 2026 Notes)

    $650,000,000 (2026 Notes)

    $1,250,000,000 (2030 Notes)

    $1,500,000,000 (2032 Notes)

    $2,000,000,000 (2034 Notes)

    $1,500,000,000 (2044 Notes)

    $2,750,000,000 (2054 Notes)

    $1,850,000,000 (2064 Notes)


    Price to Public (Issue Price):   

    100% of the Principal Amount (Floating Rate 2026 Notes)

    99.832% of the Principal Amount (2026 Notes)

    99.940% of the Principal Amount (2030 Notes)

    99.773% of the Principal Amount (2032 Notes)

    99.994% of the Principal Amount (2034 Notes)

    99.081% of the Principal Amount (2044 Notes)

    99.801% of the Principal Amount (2054 Notes)

    99.397% of the Principal Amount (2064 Notes)

    Net Proceeds (After Underwriting Discount, Before Expenses) to Issuer:

      

    $499,250,000 (99.850% of the Principal Amount) (Floating Rate 2026 Notes)

    $647,933,000 (99.682% of the Principal Amount) (2026 Notes)

    $1,244,875,000 (99.590% of the Principal Amount) (2030 Notes)

    $1,490,595,000 (99.373% of the Principal Amount) (2032 Notes)

    $1,990,880,000 (99.544% of the Principal Amount) (2034 Notes)

    $1,476,465,000 (98.431% of the Principal Amount) (2044 Notes)

    $2,723,902,500 (99.051% of the Principal Amount) (2054 Notes)

    $1,824,044,500 (98.597% of the Principal Amount) (2064 Notes)

    Interest Rate:   

    Compounded SOFR plus 0.500% (Floating Rate 2026 Notes)

    4.750% (2026 Notes)

    4.800% (2030 Notes)

    4.950% (2032 Notes)

    5.150% (2034 Notes)

    5.500% (2044 Notes)

    5.625% (2054 Notes)

    5.750% (2064 Notes)


    Interest Payment Dates:   

    January 15, April 15, July 15 and October 15, commencing October 15, 2024 (Floating Rate 2026 Notes)

    January 15 and July 15, commencing January 15, 2025 (2026 Notes)

    January 15 and July 15, commencing January 15, 2025 (2030 Notes)

    January 15 and July 15, commencing January 15, 2025 (2032 Notes)

    January 15 and July 15, commencing January 15, 2025 (2034 Notes)

    January 15 and July 15, commencing January 15, 2025 (2044 Notes)

    January 15 and July 15, commencing January 15, 2025 (2054 Notes)

    January 15 and July 15, commencing January 15, 2025 (2064 Notes)

    Regular Record Dates:   

    The 15th calendar day (whether or not a business day) immediately preceding the applicable interest payment date (Floating Rate 2026 Notes)

    January 1 and July 1 (2026 Notes)

    January 1 and July 1 (2030 Notes)

    January 1 and July 1 (2032 Notes)

    January 1 and July 1 (2034 Notes)

    January 1 and July 1 (2044 Notes)

    January 1 and July 1 (2054 Notes)

    January 1 and July 1 (2064 Notes)

    Benchmark Treasury:   

    N/A (Floating Rate 2026 Notes)

    T 4.625% due June 30, 2026 (2026 Notes)

    T 4.250% due June 30, 2029 (2030 Notes)

    T 4.250% due June 30, 2031 (2032 Notes)

    T 4.375% due May 15, 2034 (2034 Notes)

    T 4.625% due May 15, 2044 (2044 Notes)

    T 4.250% due February 15, 2054 (2054 Notes)

    T 4.250% due February 15, 2054 (2064 Notes)

    Benchmark Treasury Price / Yield:   

    N/A (Floating Rate 2026 Notes)

    100-07 3⁄4 / 4.491% (2026 Notes)

    100-12 1⁄4 / 4.163% (2030 Notes)

    100-12 / 4.187% (2032 Notes)

    100-31+ / 4.251% (2034 Notes)

    100-19+ / 4.577% (2044 Notes)

    96-03+ / 4.489% (2054 Notes)

    96-03+ / 4.489% (2064 Notes)


    Spread to Benchmark Treasury:   

    N/A (Floating Rate 2026 Notes)

    + 35 basis points (2026 Notes)

    + 65 basis points (2030 Notes)

    + 80 basis points (2032 Notes)

    + 90 basis points (2034 Notes)

    + 100 basis points (2044 Notes)

    + 115 basis points (2054 Notes)

    + 130 basis points (2064 Notes)

    Re-offer Yield:   

    N/A (Floating Rate 2026 Notes)

    4.841% (2026 Notes)

    4.813% (2030 Notes)

    4.987% (2032 Notes)

    5.151% (2034 Notes)

    5.577% (2044 Notes)

    5.639% (2054 Notes)

    5.789% (2064 Notes)

     

    Optional Redemption Provisions:   

    The Floating Rate 2026 Notes will not be redeemable prior to maturity.

     

    Make-whole call at any time at a discount rate of U.S. Treasury plus 10 basis points (2026 Notes).

     

    Prior to December 15, 2029 (one month prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 10 basis points; par call on or after December 15, 2029 (2030 Notes).

     

    Prior to November 15, 2031 (two months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after November 15, 2031 (2032 Notes).

     

    Prior to April 15, 2034 (three months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after April 15, 2034 (2034 Notes).

     

    Prior to January 15, 2044 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after January 15, 2044 (2044 Notes).

     

    Prior to January 15, 2054 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on or after January 15, 2054 (2054 Notes).

     


       Prior to January 15, 2064 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on or after January 15, 2064 (2064 Notes).
    Change of Control:    If a Change of Control Triggering Event occurs, the Company will be required to make an offer to repurchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.
    Day Count:   

    Fixed Rate Notes: 30/360

    Floating Rate 2026 Notes: Actual/360

    CUSIP / ISIN:   

    91324P FE7 / US91324PFE79 (Floating Rate 2026 Notes)

    91324P FF4 / US91324PFF45 (2026 Notes)

    91324P FG2 / US91324PFG28 (2030 Notes)

    91324P FH0 / US91324PFH01 (2032 Notes)

    91324P FJ6 / US91324PFJ66 (2034 Notes)

    91324P FK3 / US91324PFK30 (2044 Notes)

    91324P FL1 / US91324PFL13 (2054 Notes)

    91324P FM9 / US91324PFM95 (2064 Notes)

    Joint Book-Running Managers:   

    Wells Fargo Securities, LLC

    Citigroup Global Markets Inc.

    J.P. Morgan Securities LLC

    PNC Capital Markets LLC

    RBC Capital Markets, LLC

    U.S. Bancorp Investments, Inc.

     

    Barclays Capital Inc.

    BNP Paribas Securities Corp.

    BofA Securities, Inc.

    Deutsche Bank Securities Inc.

    Goldman Sachs & Co. LLC

    Mizuho Securities USA LLC

    Morgan Stanley & Co. LLC

    TD Securities (USA) LLC

    Truist Securities, Inc.

    Senior Co-Managers:   

    BNY Mellon Capital Markets, LLC

    KeyBanc Capital Markets Inc.

    Santander US Capital Markets LLC

    Scotia Capital (USA) Inc.

    SG Americas Securities, LLC

    SMBC Nikko Securities America, Inc.


    Co-Managers:   

    Bancroft Capital, LLC

    Drexel Hamilton, LLC

    Fifth Third Securities, Inc.

    Huntington Securities, Inc.

    Loop Capital Markets LLC

    Regions Securities LLC

    R. Seelaus & Co., LLC

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time.

    **

    We expect that delivery of the Notes will be made against payment therefor on or about July 25, 2024, which will be the second business day following the date of pricing of the Notes (this settlement cycle being referred to as “T+2”). Under Rule 15c6-1 of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes on any date prior to the date that is one business day preceding the settlement date will be required, by virtue of the fact that the Notes initially will settle in T+2, to specify an alternative settlement cycle at the time of any such trade to prevent a failed settlement and should consult their own advisors.

    * * *

    The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Wells Fargo Securities, LLC toll-free at (800) 645-3751, Citigroup Global Markets Inc. toll-free at (800) 831-9146, J.P. Morgan Securities LLC collect at (212) 834-4533, PNC Capital Markets LLC toll-free at (855) 881-0697, RBC Capital Markets, LLC toll-free at (866) 375-6829 or U.S. Bancorp Investments, Inc. toll-free at (877) 558-2607.

    Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    1/6/2025$625.00 → $610.00Buy
    Truist
    10/17/2024Buy → Hold
    HSBC Securities
    10/11/2024$675.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by Raymond James

      Raymond James downgraded UnitedHealth from Strong Buy to Mkt Perform

      5/14/25 8:59:11 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by BofA Securities with a new price target

      BofA Securities downgraded UnitedHealth from Buy to Neutral and set a new price target of $350.00

      5/14/25 8:59:06 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Buy to Hold and set a new price target of $490.00

      4/22/25 7:23:13 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    SEC Filings

    See more
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      5/14/25 6:01:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by UnitedHealth Group Incorporated

      SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      5/7/25 10:07:23 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/29/25 4:02:36 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Financials

    Live finance-specific insights

    See more

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UnitedHealth Group Announces Leadership Transition

      Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company

      5/13/25 6:30:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh

      3/12/25 4:20:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Leadership Transition

      Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company

      5/13/25 6:30:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • CareXM adds Home-Based Care Industry Leader, Carla Davis, to its Board of Directors

      CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa

      5/7/25 8:46:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    See more
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care